UMPC Hillman Cancer Center — Pittsburgh, Pennsylvania

UMPC Hillman Cancer Center is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

UMPC Hillman Cancer Center has participated in 6 clinical trials with 4 currently active.

Therapeutic areas: Ovarian Cancer, Thrombocythemia, Essential, Primary Myelofibrosis.

Sponsors: Kalinski, Pawel, MD, PhD, Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA), Megan Mantica.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pittsburgh

Browse all research sites in Pennsylvania · View every site in Pittsburgh

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UMPC Hillman Cancer Center?

UMPC Hillman Cancer Center has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UMPC Hillman Cancer Center conducted?

UMPC Hillman Cancer Center has 6 clinical trials on record, with 4 currently active. Their work covers Ovarian Cancer, Thrombocythemia, Essential, Primary Myelofibrosis.

Is UMPC Hillman Cancer Center accredited by Crixeo Clinical Trials?

UMPC Hillman Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UMPC Hillman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.